Comparison of Switch to Fingolimod or Interferon Beta/Glatiramer Acetate in Active Multiple Sclerosis

Anna He, Tim Spelman, Vilija Jokubaitis, Eva Havrdova, Dana Horakova, Maria Trojano, Alessandra Lugaresi, Guillermo Izquierdo, Pierre Grammond, Pierre Duquette, Marc Girard, Eugenio Pucci, Gerardo Iuliano, Raed Alroughani, Celia Oreja-Guevara, Ricardo Fernandez-Bolanos, Francois Grand'Maison, Patrizia Sola, Daniele Spitaleri, Franco GranellaMurat Terzi, Jeannette Lechner-Scott, Vincent Van Pesch, Raymond Hupperts, Jose Luis Sanchez-Menoyo, Suzanne Hodgkinson, Csilla Rozsa, Freek Verheul, Helmut Butzkueven, Tomas Kalincik

Research output: Contribution to journalArticleAcademicpeer-review

35 Citations (Scopus)
Original languageEnglish
Pages (from-to)405-413
JournalJAMA Neurology
Volume72
Issue number4
DOIs
Publication statusPublished - Apr 2015

Cite this

He, A., Spelman, T., Jokubaitis, V., Havrdova, E., Horakova, D., Trojano, M., Lugaresi, A., Izquierdo, G., Grammond, P., Duquette, P., Girard, M., Pucci, E., Iuliano, G., Alroughani, R., Oreja-Guevara, C., Fernandez-Bolanos, R., Grand'Maison, F., Sola, P., Spitaleri, D., ... Kalincik, T. (2015). Comparison of Switch to Fingolimod or Interferon Beta/Glatiramer Acetate in Active Multiple Sclerosis. JAMA Neurology, 72(4), 405-413. https://doi.org/10.1001/jamaneurol.2014.4147